Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy XBiotech stock
Learn how to easily invest in XBiotech stock.
XBiotech Inc is a biotechnology business based in the US. XBiotech shares (XBIT) are listed on the NASDAQ and all prices are listed in US Dollars. XBiotech employs 95 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in XBiotech
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XBIT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
XBiotech stock price (NASDAQ: XBIT)Use our graph to track the performance of XBIT stocks over time.
XBiotech shares at a glance
|Latest market close||$10.24|
|52-week range||$10.71 - $20.75|
|50-day moving average||$12.37|
|200-day moving average||$15.09|
|Wall St. target price||$18.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.43|
Buy XBiotech shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy XBiotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
XBiotech price performance over time
|1 week (2022-01-14)||-11.72%|
|1 month (2021-12-23)||-9.30%|
|3 months (2021-10-22)||-27.27%|
|6 months (2021-07-23)||-35.88%|
|1 year (2021-01-22)||-39.23%|
|2 years (2020-01-22)||-54.65%|
|3 years (2019-01-22)||76.55%|
|5 years (2017-01-20)||11.64|
|Revenue TTM||$19.2 million|
|Gross profit TTM||$9.4 million|
|Return on assets TTM||-4.51%|
|Return on equity TTM||-4.12%|
|Market capitalisation||$352.6 million|
TTM: trailing 12 months
XBiotech share dividends
We're not expecting XBiotech to pay a dividend over the next 12 months.
XBiotech share price volatility
Over the last 12 months, XBiotech's shares have ranged in value from as little as $10.71 up to $20.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XBiotech's is 1.4921. This would suggest that XBiotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
XBiotech Inc. , a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and True Human COVID-19 therapy for treating the COVID-19 mutant virus. In addition, the company provides clinical trial contract research operations to conduct two large, double-blind placebo-controlled Phase II clinical studies. The company was incorporated in 2005 and is headquartered in Austin, Texas. .
XBiotech in the news
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questionsWhat percentage of XBiotech is owned by insiders or institutions?
Currently 39.964% of XBiotech shares are held by insiders and 21.731% by institutions. How many people work for XBiotech?
Latest data suggests 95 work at XBiotech. When does the fiscal year end for XBiotech?
XBiotech's fiscal year ends in December. Where is XBiotech based?
XBiotech's address is: 5217 Winnebago Lane, Austin, TX, United States, 78744 What is XBiotech's ISIN number?
XBiotech's international securities identification number is: CA98400H1029 What is XBiotech's CUSIP number?
XBiotech's Committee on Uniform Securities Identification Procedures number is: 98400H102
More guides on Finder
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert